CENTRAL TRUST Co - BLUEPRINT MEDICINES CORP ownership

BLUEPRINT MEDICINES CORP's ticker is BPMC and the CUSIP is 09627Y109. A total of 278 filers reported holding BLUEPRINT MEDICINES CORP in Q4 2020. The put-call ratio across all filers is 4.17 and the average weighting 0.2%.

Quarter-by-quarter ownership
CENTRAL TRUST Co ownership history of BLUEPRINT MEDICINES CORP
ValueSharesWeighting
Q3 2023$1,15623
+283.3%
0.00%
Q2 2022$060.0%0.00%
Q1 2022$0
-100.0%
6
-96.0%
0.00%
Q4 2021$16,000
+6.7%
1500.0%0.00%
-100.0%
Q3 2021$15,000
+15.4%
1500.0%0.00%
Q2 2021$13,000
+160.0%
150
+200.0%
0.00%
Q1 2021$5,000
+66.7%
50
+66.7%
0.00%
Q4 2020$3,000
-40.0%
30
-40.0%
0.00%
Q3 2020$5,000
+25.0%
500.0%0.00%
Q2 2020$4,000500.00%
Other shareholders
BLUEPRINT MEDICINES CORP shareholders Q4 2020
NameSharesValueWeighting ↓
Aquilo Capital Management, LLC 645,539$69,144,0007.84%
DAFNA Capital Management LLC 206,911$22,162,0005.57%
Eagle Health Investments LP 192,639$20,634,0005.03%
Casdin Capital, LLC 1,550,000$166,021,0004.68%
CADIAN CAPITAL MANAGEMENT, LP 450,657$48,270,0002.65%
Avidity Partners Management LP 995,000$106,574,0002.26%
Integral Health Asset Management, LLC 75,000$8,033,0002.22%
Rock Springs Capital Management LP 859,755$92,088,0002.13%
Boxer Capital, LLC 507,374$54,345,0002.11%
EFG Asset Management (North America) Corp. 112,715$12,082,0001.58%
View complete list of BLUEPRINT MEDICINES CORP shareholders